Literature DB >> 6163726

Interferon production by human mononuclear leukocytes: differences between respiratory syncytial virus and influenza viruses.

T Chonmaitree, N J Roberts, R G Douglas, C B Hall, R L Simons.   

Abstract

The ability of respiratory syncytial virus (RSV) to induce interferon production by human mononuclear leukocytes was compared with that of influenza viruses. Cell culture fluids were assayed for interferon activity 1, 3 and 7 days after exposure to RSV or to one of two subtypes of influenza A virus (H0N1 and H3N2). RSV induced interferon production inconsistently and in low titers. Varying the multiplicity of infection did not improve the ability of RSV to induce interferon production. In contrast, influenza viruses were effective inducers of interferon production. Seropositivity to the influenza virus strains was not associated with increased interferon titers. Interferon produced after exposure to RSV or to the influenza viruses was resistant to low pH treatment. The data suggest that interferon production may not be a major component of human immunological defense against RSV infection.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6163726      PMCID: PMC350621          DOI: 10.1128/iai.32.1.300-303.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Inactivation of myxoviruses by lymphoid cells.

Authors:  B Zisman; A M Denman
Journal:  J Gen Virol       Date:  1973-08       Impact factor: 3.891

2.  Virus-induced interferon production by human macrophages.

Authors:  N J Roberts; R G Douglas; R M Simons; M E Diamond
Journal:  J Immunol       Date:  1979-07       Impact factor: 5.422

3.  Interferon and respiratory syncytial virus.

Authors:  G Corbitt
Journal:  Lancet       Date:  1971-08-28       Impact factor: 79.321

4.  Interferon and respiratory syncytial virus.

Authors:  P S Gardner; R McGuckin; A Beale; R Fernandes
Journal:  Lancet       Date:  1970-03-14       Impact factor: 79.321

5.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  Sensitivity of common respiratory viruses to an interferon inducer in human cells.

Authors:  D A Hill; S Baron; R M Chanock
Journal:  Lancet       Date:  1969-07-26       Impact factor: 79.321

7.  General considerations of the interferon system.

Authors:  S Baron; F Dianzani
Journal:  Tex Rep Biol Med       Date:  1977

8.  Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants.

Authors:  P F Wright; T Shinozaki; W Fleet; S H Sell; J Thompson; D T Karzon
Journal:  J Pediatr       Date:  1976-06       Impact factor: 4.406

9.  Immune specific production of interferon by human T cells in combined macrophage-lymphocyte cultures in response to Herpes simplex antigen.

Authors:  M J Valle; A M Bobrove; S Strober; T C Merigan
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

10.  Comparative production of interferon by human fetal, neonatal, and maternal cells.

Authors:  W A Carter; K R Hande; B Essien; E Prochownik; M M Kaback
Journal:  Infect Immun       Date:  1971-05       Impact factor: 3.441

View more
  18 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

2.  Surveillance of respiratory viral infections by rapid immunofluorescence diagnosis, with emphasis on virus interference.

Authors:  G Anestad
Journal:  Epidemiol Infect       Date:  1987-10       Impact factor: 2.451

3.  Production of interferon in respiratory syncytial virus bronchiolitis.

Authors:  D Isaacs
Journal:  Arch Dis Child       Date:  1989-01       Impact factor: 3.791

4.  Suppressed expression of ICAM-1 and LFA-1 and abrogation of leukocyte collaboration after exposure of human mononuclear leukocytes to respiratory syncytial virus in vitro. Comparison with exposure to influenza virus.

Authors:  A R Salkind; J E Nichols; N J Roberts
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

5.  Reduced activation and proliferation of human lymphocytes exposed to respiratory syncytial virus compared to cells exposed to influenza virus.

Authors:  Elisa H Fleming; Eliana E Ochoa; Joan E Nichols; M Kerry O'Banion; Alan R Salkind; Norbert J Roberts
Journal:  J Med Virol       Date:  2017-09-26       Impact factor: 2.327

6.  Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins.

Authors:  Jean-Francois Valarcher; Julie Furze; Sara Wyld; Roy Cook; Karl-Klaus Conzelmann; Geraldine Taylor
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

7.  Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus.

Authors:  T Rothoeft; K Fischer; S Zawatzki; V Schulz; U Schauer; C Körner Rettberg
Journal:  Clin Exp Immunol       Date:  2007-09-24       Impact factor: 4.330

8.  Different effects of influenza virus, respiratory syncytial virus, and Sendai virus on human lymphocytes and macrophages.

Authors:  N J Roberts
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

9.  Interferon-induced 2-5A synthetase activity in human peripheral blood mononuclear cells after immunization with influenza virus and rubella virus vaccines.

Authors:  L J Penn; B R Williams
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

10.  Interferon alfa, infectious virus, and virus antigen secretion in respiratory syncytial virus infections of graded severity.

Authors:  C E Taylor; M S Webb; A D Milner; P D Milner; L A Morgan; R Scott; G M Stokes; A S Swarbrick; G L Toms
Journal:  Arch Dis Child       Date:  1989-12       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.